Proportion of isolates with decreased susceptibility or resistance in Canada

Canada: Proportion of isolates with decreased susceptibility or resistance was 0.5445 in 2018. ◆ Volatile

Latest (2018)
0.5445
Change on year
down 20.1%
World rank
20th
of 51 countries
All-time high
7.34
in 2010
All-time low
0.5445
in 2018
Years of data
10
2009–2018

Proportion of isolates with decreased susceptibility or resistance in Canada, 2009–2018

024682009201320182009: 3.12010: 7.32011: 6.22012: 5.52013: 3.52014: 3.32015: 3.52016: 1.82017: 0.6812018: 0.545

Source: World Health Organization, Global Health Observatory.

Analysis

Canada recorded 0.5445 for proportion of isolates with decreased susceptibility or resistance in 2018. That is the lowest value across all 10 years on record.

Compared with earlier readings it is down 20.1% on the previous year and down 82.4% over ten years.

Over the whole period, proportion of isolates with decreased susceptibility or resistance in Canada peaked at 7.34 in 2010 and was at its lowest, 0.5445, in 2018.

Canada ranks 20th of 51 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Proportion of isolates with decreased susceptibility or resistance in Canada, year by year

Annual values for Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP in Canada, 2009 to 2018.
Year Value Change
2009 3.09
2010 7.34 +137.5%
2011 6.19 -15.7%
2012 5.53 -10.6%
2013 3.51 -36.7%
2014 3.25 -7.2%
2015 3.48 +7.2%
2016 1.76 -49.4%
2017 0.6812 -61.4%
2018 0.5445 -20.1%

Averages by decade

DecadeAverage LowestHighest Years
2000s 3.09 3.09 3.09 1
2010s 3.59 0.5445 7.34 9

Countries ranked near Canada

  1. 17 United Kingdom of Great Britain and Northern Ireland 1.2 compare
  2. 18 Germany 1 compare
  3. 19 Mongolia 0.7752 compare
  4. 21 Thailand 0.4587 compare
  5. 22 New Zealand 0.4386 compare
  6. 23 United States of America 0.2907 compare

See the full ranking of 51 places →

More health data for Canada

All data for Canada →

Frequently asked questions

What is proportion of isolates with decreased susceptibility or resistance in Canada?
Proportion of isolates with decreased susceptibility or resistance in Canada was 0.5445 in 2018, according to World Health Organization, Global Health Observatory.
What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Canada?
The highest recorded value was 7.34 in 2010.
What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Canada?
The lowest recorded value was 0.5445 in 2018.
How does Canada rank for proportion of isolates with decreased susceptibility or resistance?
Canada ranks 20th out of 51 countries with data for 2018.
Is proportion of isolates with decreased susceptibility or resistance rising or falling in Canada?
Over the last ten years it is down 82.4%. The long-run trend across the full record is volatile.
Where does this Canada data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of isolates with decreased susceptibility or resistance in Canada. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 09 September 2026, from https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-extended/canada/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-extended/canada/">Proportion of isolates with decreased susceptibility or resistance in Canada</a> — Statizoid

About this data

Indicator
Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
51 places, 436 data points, 2009–2018
Last refreshed